human cord blood-derived mononuclear cells (HCB-MNCs)
2022-SR-752
Unknown mab active
Quick answer
human cord blood-derived mononuclear cells (HCB-MNCs) for Refractory Diabetic Foot is a Unknown program (mab) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Refractory Diabetic Foot
- Phase
- Unknown
- Modality
- mab
- Status
- active